December 21, 2007 - Royal Philips Electronics announced it will acquire U.S.-based healthcare firm Respironics Inc. for $5.1 billion.
Respironics is a global leader in the treatment of Obstructive Sleep Apnea (OSA), a sleep disorder characterized by the repeated cessation of breathing during sleep. It is estimated that in the U.S. alone there are 18-20 million sufferers of moderate or severe OSA of which only 15-20 percent have been diagnosed.